NCT06864221View on ClinicalTrials.gov

Plasma Sphingolipid Metabolites and Radiotherapy Efficacy in Hepatocellular Carcinoma

RecruitingOBSERVATIONAL
Enrollment

260

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

January 1, 2026

Study Completion Date

June 1, 2026

Conditions
Hepatocellular CarcinomaRadiotherapyTreatment OutcomeBiomarkersSphingolipids
Trial Locations (1)

510515

RECRUITING

Nanfang Hospital, Southern Medical University, Guangzhou

All Listed Sponsors
lead

Nanfang Hospital, Southern Medical University

OTHER